Effect of subdermal levonorgestrel contraceptive implants, Norplant, on liver functions. 1984

M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly

Forty-seven normal health women were studied longitudinally for changes in liver functions during the use of the levonorgestrel contraceptive implant system, NORPLANT. Samples were collected before insertion of the implants and after one, three and six months of use. The enzymes studied were the transaminases (SGOT and SGPT), alkaline phosphatase and gamma-glutamyl transferase. Serum bilirubin and bile acid levels were also measured. The protein synthetic function of the liver was tested by estimation of total proteins, albumin, transferrin, hemopexin, ceruloplasmin and haptoglobin. The three main immunoglobulins, G, M and A, were also measured. There were no significant changes in the liver enzymes after NORPLANT use. Serum bilirubin and bile acid concentrations showed rises in the first month of use which ameliorated in subsequent months. Serum albumin was transiently increased during the first and third months. Ceruloplasmin decreased significantly at the sixth month. The concentrations of total serum proteins and the other individual proteins showed no significant change. The results point to safety of NORPLANT implant use, as regards hepatic functions.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D009644 Norgestrel A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis. 18,19-Dinorpregn-4-en-20-yn-3-one, 13-ethyl-17-hydroxy-, (17alpha)-(+-)-,DL-Norgestrel,Neogest,Ovrette,Postinor,Wy-3707,DL Norgestrel,Wy 3707,Wy3707
D002570 Ceruloplasmin A multi-copper blood FERROXIDASE involved in iron and copper homeostasis and inflammation. Caeruloplasmin,Ferroxidase,Ceruloplasmin Ferroxidase,Ceruloplasmin Oxidase,Ferroxidase I,alpha(2)-Ceruloplasmin,Ferroxidase, Ceruloplasmin,Oxidase, Ceruloplasmin
D003277 Contraceptives, Oral, Combined Fixed drug combinations administered orally for contraceptive purposes. Combined Oral Contraceptive,Contraceptive Agents, Female, Combined,Oral Contraceptives, Combined,Combined Oral Contraceptives,Contraceptive, Combined Oral,Contraceptives, Combined Oral,Oral Contraceptive, Combined
D004343 Drug Implants Small containers or pellets of a solid drug implanted in the body to achieve sustained release of the drug. Drug Implant,Drug Pellet,Pellets, Drug,Drug Pellets,Implant, Drug,Implants, Drug,Pellet, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001647 Bile Acids and Salts Steroid acids and salts. The primary bile acids are derived from cholesterol in the liver and usually conjugated with glycine or taurine. The secondary bile acids are further modified by bacteria in the intestine. They play an important role in the digestion and absorption of fat. They have also been used pharmacologically, especially in the treatment of gallstones. Bile Acid,Bile Salt,Bile Salts,Bile Acids,Acid, Bile,Acids, Bile,Salt, Bile,Salts, Bile

Related Publications

M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
June 1986, Advances in contraception : the official journal of the Society for the Advancement of Contraception,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
March 2000, American journal of obstetrics and gynecology,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
January 1991, MCN. The American journal of maternal child nursing,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
February 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
September 1994, East African medical journal,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
February 1993, Contraception,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
January 1992, American journal of obstetrics and gynecology,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
March 1981, Fertility and sterility,
M M Shaaban, and S I Elwan, and M M el-Sharkawy, and A S Farghaly
March 1989, Advances in contraception : the official journal of the Society for the Advancement of Contraception,
Copied contents to your clipboard!